SUNNY LOWE: Open Payments
NPI 1457052821 · SALISBURY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$543 in 27 payments from 10 companies in 2025. Trend: 2023 $315 · 2024 $463 · 2025 $543
Food & beverage: $543
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $168 |
| Exact Sciences Corporation | 4 | $94 |
| Novo Nordisk Inc | 4 | $79 |
| Astellas Pharma US Inc | 2 | $47 |
| SANOFI-AVENTIS U.S. LLC | 1 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| PFIZER INC. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: MOUNJARO, Cologuard Collection Kit, Wegovy, Veozah, TZIELD, Kerendia, GEMTESA, EVKEEZA.
Industry payments across MD — which companies pay providers there.
